| Bioactivity | TRV-7019 is a BBB-penetrable radioligand for brain imaging that target butyrylcholinesterase. TRV-7019 can be used for the diagnosis of an amyloid disease, multiple sclerosis, a brain tumor, or butyrylcholinesterase activity[1]. | ||||||||||||
| Name | TRV-7019 | ||||||||||||
| CAS | 2598164-15-7 | ||||||||||||
| Formula | C14H12INO3 | ||||||||||||
| Molar Mass | 369.15 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sultan Darvesh, et al. Butyrylcholinesterase compounds and use in diseases of the nervous system. Patent WO2021026429A1. |
TRV-7019
CAS: 2598164-15-7 F: C14H12INO3 W: 369.15
TRV-7019 is a BBB-penetrable radioligand for brain imaging that target butyrylcholinesterase. TRV-7019 can be used for t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.